Valor20202021202220232024Total de passivos405.62 M583.06 M678.45 M703.49 M683.1 MCapital total2.21 B2.49 B2.26 B2.24 B2.16 BTotal de passivos e patrimônio líquido2.62 B3.07 B2.94 B2.95 B2.84 BDívida total—————Dívida líquida—————
Exelixis, Inc. - Common Stock
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.